for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

GAVI signs COVID-19 vaccine supply deal with J&J

GENEVA, May 21 (Reuters) - The GAVI Vaccine Alliance has signed an advanced purchase agreement with Johnson & Johnson for 200 million doses of its COVID-19 vaccine for the COVAX vaccine-sharing programme, it said in a statement on Friday.

GAVI said the goal was to have the doses available in 2021 and for both self-financing participants of COVAX as well as poorer countries.

“As a one dose vaccine, the J&J vaccine has particular relevance for places with difficult infrastructure, making it a very important addition to the portfolio,” said GAVI CEO Seth Berkley. (Reporting by Emma Farge Editing by Caroline Copley)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up